Cite
HARVARD Citation
Feuerstadt, P. et al. (n.d.). 522. Significant Improvement in Health-Related Quality of Life (HRQL) with RBX2660: Results from a Phase 3 Randomized, Placebo-Controlled Trial in Recurrent Clostridioides Difficile Infection (PUNCH CD3). Open forum infectious diseases. p. . [Online].